Stocks · Healthcare · Medical - Devices
Integer Holdings Corporation ITGR
$126.45 +0.02% Close, Oct 2, 2026 · NYSE · Market cap $4.29B
Strong trend
Next earnings report: Oct 22, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $3.66, up 61.2% year over year.
- Net debt is 4.3× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 99 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 35%
- EPS growth (TTM, YoY)Top 24%
- FCF growth (TTM, YoY)Bottom 35%
- Revenue growth, 3-year CAGRTop 47%
- Revenue growth accelerationBottom 31%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 23%
- Gross marginBottom 16%
- Operating marginTop 27%
- Cash conversion (OCF / net income)Top 50%
- Accruals (lower is better)Bottom 25%
- Net debt / EBITDA (lower is better)Bottom 18%
- Interest coverTop 27%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 28%
- EBITDA / enterprise valueTop 21%
- Sales / enterprise valueTop 39%
- P/E vs own 5-year history (lower is better)Bottom 46%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 50%
- 6-month returnTop 21%
- 1-year return vs S&P 500Top 42%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 44%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetBottom 7%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 24%
- Maximum drawdown, 3 yearsTop 30%
- Beta vs S&P 500 (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Bottom 18%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.0% | 2.9% | ↓ |
| EPS growth (YoY) | 90.0% | 61.2% | ↓ |
| Gross margin | 25.0% | 23.7% | ↓ |
| Operating margin | 12.3% | 9.5% | ↓ |
| FCF margin | 6.7% | 6.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 2.9% | 6.0% | ↓ | Bottom 35% |
| EPS growth (TTM, YoY) | 61.2% | 90.0% | ↓ | Top 24% |
| Gross margin | 23.7% | 25.0% | ↓ | Bottom 16% |
| Operating margin | 9.5% | 12.3% | ↓ | Top 27% |
| Net margin | 7.0% | 4.6% | ↑ | — |
| Free-cash-flow margin | 6.1% | 6.7% | ↓ | — |
| Return on invested capital | 5.1% | — | Top 23% | |
| Revenue growth, 3-year CAGR | 11.5% | — | Top 47% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.60×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -19.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.29×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 4.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.41%
- Shareholder yield
- 2.41%
- Share count change, 1 year
- -4.4%
- Share count change, 3-year CAGR
- +0.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 3, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +6.3%
- Average 2-day reaction, last 8
- -5.0%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $118.25
- Target vs current price
- -6.5%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 50%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | +15.9% | +2.7% | +3.3% | +3.4% | — |
| Apr 30, 2026 | -0.8% | +5.8% | +3.1% | +7.6% | +18.8% |
| Feb 19, 2026 | +3.5% | -4.0% | +0.0% | -2.1% | +3.9% |
| Oct 23, 2025 | +6.5% | -32.3% | -40.2% | -38.0% | -22.0% |
| Jul 24, 2025 | -1.3% | -7.5% | -6.1% | -7.3% | -10.9% |
| Apr 24, 2025 | +3.1% | +0.8% | +4.8% | -1.4% | -7.4% |
| Feb 20, 2025 | -2.1% | -5.6% | -11.8% | -15.7% | -16.9% |
| Oct 24, 2024 | +5.1% | +0.2% | +2.7% | +5.4% | +11.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | $1.60 | $1.38 | +15.9% | $464.1M |
| Apr 30, 2026 | $1.20 | $1.21 | -0.8% | $439.6M |
| Feb 19, 2026 | $1.76 | $1.70 | +3.5% | $472.1M |
| Oct 23, 2025 | $1.79 | $1.68 | +6.5% | $467.7M |
| Jul 24, 2025 | $1.55 | $1.57 | -1.3% | $476.5M |
| Apr 24, 2025 | $1.31 | $1.27 | +3.1% | $437.4M |
| Feb 20, 2025 | $1.43 | $1.46 | -2.1% | $449.5M |
| Oct 24, 2024 | $1.43 | $1.36 | +5.1% | $431.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 34.5× | 34.6× | 48th | Top 19% |
| P/E (forward) | 20.5× | — | — | — |
| EV / EBITDA | 18.0× | — | — | Top 21% |
| EV / Sales | 3.06× | — | — | Top 39% |
| Free-cash-flow yield | 2.61% | — | — | Top 28% |
| Earnings yield | 2.89% | — | — | Top 19% |
P/E over the past five years
Range 22.1× – 57.6× since Jul 2, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +22.9%
- Earnings per share growth (TTM)
- +61.2%
- Change in P/E multiple
- -27.6%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 99
- Days above the 200-day average
- 99
- 50-day average slope (20 days)
- +11.5%
- 200-day average slope (20 days)
- +6.2%
- Distance from 50-day average
- +2.8%
- Distance from 200-day average
- +31.6%
- RSI (14)
- 74.2
- Relative volume
- 0.58×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 41.3%
- Volatility vs own 5-year history
- 86th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.50
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -0.0%
- Maximum drawdown, 3 years
- -56.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 28, 2025 | Oct 30, 2025 | -56.1% | 191 days | Not yet recovered |
| Jul 29, 2021 | Oct 10, 2022 | -48.7% | 302 days | 300 days (Dec 19, 2023) |
| Oct 16, 2020 | Nov 4, 2020 | -16.4% | 13 days | 4 days (Nov 10, 2020) |
| Jul 22, 2024 | Aug 5, 2024 | -14.6% | 10 days | 19 days (Aug 30, 2024) |
| Jan 7, 2021 | Jan 29, 2021 | -11.4% | 15 days | 14 days (Feb 19, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $4.29B
- P/E (TTM)
- 34.5
- EPS, diluted (TTM)
- $3.66
- Revenue (TTM)
- $1.84B
- 52-week range
- $62.00 – $126.80
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.22B | $1.33B | $1.56B | $1.72B | $1.85B |
| Gross profit | $337.0M | $346.7M | $411.5M | $461.2M | $425.8M |
| Operating income | $135.7M | $112.7M | $163.3M | $208.2M | $209.3M |
| Net income | $96.8M | $66.4M | $90.7M | $119.9M | $102.8M |
| EPS (diluted) | $2.80 | $1.96 | $2.69 | $3.40 | $2.89 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $431.4M | $449.5M | $436.2M | $472.8M | $466.6M | $470.9M | $439.6M | $464.1M |
| Net income | $35.4M | $32.7M | -$22.5M | $37.0M | $39.7M | $48.6M | $16.5M | $23.6M |
| EPS (diluted) | $0.99 | $0.90 | -$0.66 | $1.04 | $1.11 | $1.38 | $0.48 | $0.69 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $156.7M | $116.4M | $180.2M | $205.2M | $196.1M |
| Capital expenditure | -$53.5M | -$74.7M | -$119.9M | -$105.4M | -$91.0M |
| Free cash flow | $103.2M | $41.7M | $60.3M | $99.8M | $105.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$4.6M | -$2.9M | -$3.1M | $742,000 | -$46.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $21.4M
- Total assets
- $3.42B
- Total liabilities
- $1.70B
- Total debt
- $1.36B
- Net debt
- $1.34B
- Shareholders’ equity
- $1.72B
As of Jul 3, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 2,569,857
- Days to cover
- 3.21
- Change vs previous report
- -1.0%
FINRA short interest, settlement date Sep 15, 2026.